Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: Aliment Pharmacol Ther. 2020 May 3;51(12):1397–1405. doi: 10.1111/apt.15749

Table 1:

Baseline Characteristics of Study Cohort

Clinical Characteristics at the time of Hepatic Encephalopathy Diagnosis Patients with Hepatic Encephalopathy (N=49,164)

Age, median (IQR) 63 (55, 71)

Sex, male, n (%) 27,515 (56)

White Race, n (%) 38,076 (78)

Medicaid co-insurance, n (%) 15,293(31)

Urban, n (%) 39,827 (81)

Charlson Index
 0 17,259 (35)
 1 17,714 (36)
 2 10,462 (21)
 ≥3 3,324 (7)

Endstage Renal Disease, n (%) 1,828 (4)

Disabled, n (%) 22,259 (46)

Cirrhosis etiology, n (%)
 Alcohol 24,183 (50)
 Hepatitis C 18,352 (38)
 Non-alcohol, non-viral 15,048 (31)
 Hepatitis B 2,589 (5)

Ascites, n(%) 20,771 (43)

Paracentesis, n(%) 6,474 (13)

Varices, n(%) 10,297 (21)

Transjugular intrahepatic portosystemic shunt, n(%) 704 (1)

Hepatocellular Carcinoma, n(%) 3,361 (7)

Gastroenterology consult, n(%) 24,090 (49)

HE= Hepatic encephalopathy, Note: many patients had both alcohol-related and hepatitis C cirrhosis.